Location History:
- Horne Horley, GB (2014)
- London, GB (2020 - 2022)
Company Filing History:
2 out of 143 
1 out of 167 Years Active: 2014-2022
Title: The Innovative Contributions of Robin John Leatherbarrow
Introduction
Robin John Leatherbarrow is a notable inventor based in London, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his work on inhibitors of N-myristoyl transferase. With a total of 3 patents to his name, Leatherbarrow's inventions have the potential to impact the treatment of various diseases.
Latest Patents
One of Leatherbarrow's latest patents focuses on compounds and their use as inhibitors of N-myristoyl transferase (NMT). This invention provides compounds of formula (I) and salts thereof, which exhibit activity as inhibitors of NMT. The invention also relates to the use of such compounds as medicaments, particularly in treating diseases or disorders where inhibition of N-myristoyl transferase offers therapeutic or prophylactic effects. These include protozoan infections such as malaria and leishmaniasis, viral infections like human rhinovirus and HIV, and hyperproliferative disorders such as B-cell lymphoma.
Career Highlights
Leatherbarrow has worked with prominent organizations, including Imperial College Innovations Limited and Imperial Innovations Limited. His work in these institutions has allowed him to further his research and development in the field of medicinal chemistry.
Collaborations
Some of his notable coworkers include Edward William Tate and Andrew Simon Bell. Their collaborative efforts have contributed to the advancement of research in their respective fields.
Conclusion
Robin John Leatherbarrow's innovative work in developing inhibitors of N-myristoyl transferase showcases his commitment to advancing medical science. His contributions have the potential to lead to significant therapeutic advancements in treating various diseases.